Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery

Feng Zhang, Ke Liu, Mengdan Cao, Jing Qu, Dengming Zhou, Zheng Pan, Xuanchu Duan, Yong Zhou

Investigative Ophthalmology & Visual Science · 2019 · 27 citations · 12 references

DOIFull text

Open access

Abstract

RSG treatment prevents subconjunctival fibrosis after GFS by inhibition of profibrotic gene expression through a mechanism involved in promoting autophagy in local fibroblasts. RSG represents a novel antifibrotic drug with the potential to improve the success rate of GFS.

References

12